Clues to Why a Breakthrough Pancreatic Cancer Drug Eventually Stops Working

New York Times - Sep 30, 2026

Researchers are asking why patients, like former Senator Ben Sasse, inevitably develop resistance to the drug daraxonrasib.

Read full article

More News

Science Tech Today

Provides daily Science and Technology news on scientific research with the hopes to invite and build a community to explore the multiple scientific research.

NEWSLETTER